Overview

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response

Status:
Completed
Trial end date:
2012-06-15
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled, crossover study to evaluate the pressor effects of pseudoephedrine when administered with TR-701 FA in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Trius Therapeutics LLC
Treatments:
Tedizolid
Tedizolid phosphate
Torezolid phosphate